Panel: Iberia M&A Outlook

Globally, M&A is expected to pick up in second half of 2023 with financial sponsors ready to deploy capital and well-capitalised companies looking to make acquisitions to their core business. However, Iberian dealmaking faces some challenges ahead including updates to Spanish corporate law, changes to insolvency frameworks and more scrutiny on FDI regulation. This panel will discuss: 

  • How will new regulations affect cross-border M&A in key sectors such as TMT, financial services, and energy? 
  • How are private equity and venture capital investments bolstering the deal pipeline?
  • Will Iberia see more public M&A in the second half of 2023?
  • How are deals being financed? Private lenders or via banks?
  • What are the risk appetites of acquirers deal sourcing in Europe at the moment?
  • Speakers keyboard_arrow_down
    Mario Pardo Managing Director Carlyle Bio
    Jesús Quintanal Co-head of Corporate Finance Europe Santander CIB Bio
    Andrejs Klisans Country Manager 36Brains Bio
    Juan Muro-Lara Chief Strategy and Corporate Development Officer Acciona Bio
    José Luis Rodríguez Partner Cuatrecasas Bio